These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9802389)

  • 21. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
    Zhao XH; Sun XY; Edvinsson L; Hedner T
    J Hypertens; 1997 Jan; 15(1):19-27. PubMed ID: 9050966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide Y Y1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells.
    Van Liefde ; Vanderheyden PM; De Backer JP; Ebinger G; Vauquelin G
    J Recept Signal Transduct Res; 2001 Feb; 21(1):11-23. PubMed ID: 11693170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the guanidine-acylguanidine bioisosteric approach to argininamide-type NPY Y₂ receptor antagonists.
    Pluym N; Brennauer A; Keller M; Ziemek R; Pop N; Bernhardt G; Buschauer A
    ChemMedChem; 2011 Sep; 6(9):1727-38. PubMed ID: 21692185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist.
    Hoffmann S; Rist B; Videnov G; Jung G; Beck-Sickinger AG
    Regul Pept; 1996 Aug; 65(1):61-70. PubMed ID: 8876037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
    Malmstrom RE; Lundberg JM
    Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.
    Keller M; Pop N; Hutzler C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    J Med Chem; 2008 Dec; 51(24):8168-72. PubMed ID: 19053784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
    Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
    Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
    Hoyo Y; McGrath JC; Vila E
    J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
    Mazumdar M; Lal B; Sakharkar AJ; Deshmukh M; Singru PS; Subhedar N
    Gen Comp Endocrinol; 2006 Nov; 149(2):190-6. PubMed ID: 16828090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y.
    Bischoff A; Freund A; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):635-40. PubMed ID: 9402044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
    Misra S; Mahavadi S; Grider JR; Murthy KS
    Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity.
    Weiss S; Keller M; Bernhardt G; Buschauer A; König B
    Bioorg Med Chem; 2010 Sep; 18(17):6292-304. PubMed ID: 20688523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
    Holliday ND; Cox HM
    Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hara H; Okada T; Hashizume H; Kii M; Ishihara Y; Ishikawa M; Shimamura M; Mihara S; Kato G; Hanasaki K; Hagishita S; Fujimoto M
    J Med Chem; 1999 Jul; 42(14):2621-32. PubMed ID: 10411482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.